HomeTARS • NASDAQ
add
Tarsus Pharmaceuticals Inc
Previous close
$52.69
Day range
$45.76 - $50.70
Year range
$20.08 - $57.14
Market cap
1.86B USD
Avg Volume
603.82K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 48.12M | 2,471.78% |
Operating expense | 57.91M | 90.97% |
Net income | -23.42M | 40.18% |
Net profit margin | -48.67 | 97.67% |
Earnings per share | -0.61 | 52.04% |
EBITDA | -24.88M | 38.86% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 316.95M | 28.38% |
Total assets | 376.30M | 40.24% |
Total liabilities | 138.82M | 153.93% |
Total equity | 237.48M | — |
Shares outstanding | 38.23M | — |
Price to book | 8.47 | — |
Return on assets | -16.70% | — |
Return on capital | -19.75% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -23.42M | 40.18% |
Cash from operations | -8.65M | 73.26% |
Cash from investing | 3.13M | -93.40% |
Cash from financing | 639.00K | -99.39% |
Net change in cash | -4.88M | -104.07% |
Free cash flow | 3.41M | 114.46% |
About
Founded
2016
Headquarters
Website
Employees
244
